Noticias de QNCX_US

Noticias del mercado

Últimas noticias sobre QNCX_US — 90 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: QNCX_US ✕ 90 resultados
09/02/2026 QNCX_US — Investing.com Nigeria
Quince Therapeutics stock soars after engaging LifeSci Capital as advisor By Investing.com
09/02/2026 QNCX_US — Yahoo Finance
Quince Therapeutics Engages LifeSci Capital as its Exclusive Financial Advisor to Explore Strategic Alternatives
09/02/2026 QNCX_US — Investing.com
Quince Therapeutics stock soars after engaging LifeSci Capital as advisor
09/02/2026 QNCX_US — Investing.com Canada ES ← EN
Las acciones de Quince Therapeutics se disparan tras contratar a LifeSci Capital como asesor Por Investing.com
03/02/2026 QNCX_US — The Globe and Mail
Quince Therapeutics Announces Significant Board of Directors Resignations
02/02/2026 QNCX_US — Clinical Trials Arena
Quince Therapeutics’ stock crashes on Phase III ataxia-telangiectasia failure
02/02/2026 QNCX_US — The Business Journals
Quince stock plunges 95% following failed clinical trial for inherited childhood disease
02/02/2026 QNCX_US — Stock Titan
Five Quince Therapeutics (QNCX) directors resign, company cites no disagreements
02/02/2026 QNCX_US — TradingView
Quince Therapeutics Announces Board Resignations
30/01/2026 QNCX_US — Investing.com
Lucid Capital Markets downgrades Quince Therapeutics stock to Sell after failed trial
30/01/2026 QNCX_US — GuruFocus
Quince Therapeutics (QNCX) Downgraded by Citizens to Market Perf
30/01/2026 QNCX_US — Citeline News & Insights
Quince Therapeutics’ Fruit Spoils As Phase III A-T Study Falls To Ground
30/01/2026 QNCX_US — Investing.com Nigeria
Quince Therapeutics stock rating downgraded to Hold by D. Boral Capital
30/01/2026 QNCX_US — BioWorld News
Quince’s eDSP on ice after Neat phase III fails in A-T
30/01/2026 QNCX_US — GuruFocus
Quince Therapeutics (QNCX) Downgraded Following Phase 3 Trial Mi
30/01/2026 QNCX_US — Stocktwits
Why Did QNCX Stock Plummet Over 90% Today?
30/01/2026 QNCX_US — Benzinga ES ← EN
Este analista de Codere Online Luxemburgo ya no es optimista; Aquí están las 3 principales rebajas del viernes
29/01/2026 QNCX_US — Business Wire
Quince Therapeutics Announces Topline Results from Pivotal Phase 3 NEAT Clinical Trial of eDSP in Ataxia-Telangiectasia
29/01/2026 QNCX_US — Investing.com
Quince Therapeutics stock tumbles after failed Phase 3 trial results
29/01/2026 QNCX_US — TradingView
Quince Therapeutics Announces Results from Phase 3 NEAT Trial

Página 4 de 5

keyboard_arrow_up